| |
| |
|
| Insider
Information: |
Dolan Matthew Vincent |
| Relationship: |
EVP Strategy and Corpo... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
42,377 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,439,935 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,377 |
|
|
| Total
Value |
$5,439,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Strategy and Corpo... |
2024-04-15 |
42,377 |
2022-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2024-04-15 |
4 |
AS |
$137.81 |
$274,242 |
D/D |
(1,990) |
42,377 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy & Corp Dev |
• – – |
2024-03-15 |
4 |
AS |
$129.18 |
$547,259 |
D/D |
(4,203) |
44,367 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate |
• – – |
2024-03-12 |
4 |
S |
$134.41 |
$901,896 |
D/D |
(6,710) |
48,570 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate |
• – – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
21,711 |
55,280 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP Corporate Strategy-Develop |
• – – |
2023-03-16 |
4 |
AS |
$115.00 |
$264,845 |
D/D |
(2,303) |
33,569 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP Corporate Strategy-Develop |
• – – |
2023-03-13 |
4 |
AS |
$106.27 |
$661,956 |
D/D |
(6,229) |
35,872 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP Corporate Strategy-Develop |
• – – |
2023-03-10 |
4 |
D |
$111.40 |
$691,119 |
D/D |
(6,204) |
42,101 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP Corporate Strategy-Develop |
• – – |
2023-03-08 |
4 |
A |
$0.00 |
$22 |
D/D |
21,769 |
48,305 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP Corporate Strategy-Develop |
• – – |
2023-03-06 |
4 |
AS |
$114.40 |
$25,854 |
D/D |
(226) |
26,536 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP Corporate Strategy-Develop |
• – – |
2022-09-01 |
4 |
AS |
$81.63 |
$408 |
D/D |
(5) |
26,536 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP Corporate Development |
• – – |
2022-03-17 |
4 |
AS |
$450.00 |
$217,800 |
D/D |
(484) |
6,634 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP Corporate Development |
• – – |
2022-03-16 |
4 |
AS |
$425.00 |
$291,550 |
D/D |
(686) |
7,118 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP Corporate Development |
• – – |
2022-03-15 |
4 |
AS |
$412.41 |
$419,009 |
D/D |
(1,016) |
7,804 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP Corporate Development |
• – – |
2022-03-09 |
4 |
D |
$406.06 |
$655,782 |
D/D |
(1,615) |
8,820 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP Corporate Development |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$3 |
D/D |
2,889 |
10,435 |
0 |
- |
|
| DXCM |
DexCom Inc |
*Officer |
• – – |
2022-03-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,546 |
|
% |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
